RightAnswer Knowledge Solutions Search Results for 108-88-3

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documents

• TOLUENE

MEDITEXT® Documents

• TOLUENE

REPROTEXT® Documents

• TOLUENE

All Other Data Sources:

CCRIS Documents

• TOLUENE

CHRIS Documents

• TOLUENE

DART Documents

• [Delayed effects produced by isopentyl ether of n-toluenesulphinic acid]
• [Effects of the couple exposures to the mixed benzene on gestational processes and pregnancy outcomes]
• [Oxicological Assessment Of Isopentane Ether Of p-Toluenesulphonic Acid]

More...

• A two-generation reproductive toxicity study in rats with 4-nitrotoluene.
• Abnormal development and growth reductions of pollock Theragra chalcogramma embryos exposed to water-soluble fractions of oil.
• Adverse effects of environmental chemicals on the outcome of human pregnancy.
• Amphetamine-like discriminative stimulus effects of the abused inhalant toluene in mice.
• An in vitro study for the teratogenic potential of xylene and toluene.
• Analytic study to evaluate associations between hazardous waste sites and birth defects--final report.
• Apparent route-dependence of the acute behavioral effects of toluene in rats: an explanation.
• Are occupational carcinogens teratogenic?
• Assessment of interactive effects of the aromatic hydrocarbons toluene, xylene and benzene on rat embryonic development in vitro.
• Binge neonatal toluene exposure results in learning deficits in the Morris water maze reversal task in rats.
• Chronic glue and paint sniffing during pregnancy: a population at risk for fetal and maternal morbidity.
• Deficits on a spatial navigation task following prenatal exposure to toluene.
• Deficits on a spatial navigation task following prenatal exposure to toluene.
• Development of an animal model of toluene embryopathy (Fetal Solvents Syndrome).
• Developmental toxicity of toluene in a two-generation study.
• Developmental toxicity of toluene in the rat.
• Developmental toxicity of toluene: evidence from animal and human studies.
• Differential effects of stress and toluene in fetal life.
• Effect of the aromatic hydrocarbons toluene, xylene and benzene on rat embryonic development in vitro.
• Effects on reproduction of styrene, toluene and xylene.
• Embryotoxicity of toluene in rats.
• Evaluation of the histopathological and developmental effects of hydrocarbon mixtures in the Japanese medaka fish.
• Exposure to aromatic hydrocarbons and complications of pregnancy.
• Fetal and neonatal effects of inhalant abuse.
• Final report on the reproductive toxicity of a chemical mixture in CD-1-Swiss mice: volume 2, laboratory supplement.
• Final report on the reproductive toxicity of a complex mixture of groundwater contaminants in Sprague-Dawley rats.
• Final report on the safety assessment of 4-amino-2-hydroxytoluene.
• Health hazard evaluation report HETA 93-1035-2686, U.S. Department of Agriculture, U.S. Forest Service, Washington, DC.
• Induction of birth defects by exposure to solvents: an in vitro study.
• Is there a fetal solvent syndrome?
• Long-lasting learning and memory impairments induced by prenatal exposure to 4-tert-butyltoluene in rats.
• Mixed chemicals (MIX): reproduction and fertility assessment in Swiss (CD-1) mice when administered in the drinking water: final study report, volume I of II.
• Multivariate method for establishing teratogenic risk of exposure to xenobiotics.
• NEUROBEHAVIORAL TERATOLOGY OF MATERNAL STRESS IN COMBINATION WITH EXPOSURE TO TOLUENE.
• Occupational exposures and birth defects: final performance report.
• Organic solvents may inflict maternal toxicity not normally assessed in neurobehavioural teratology studies, e.g. hearing impairment.
• Prenatal and postnatal undernutrition and postnatal toluene inhalation on spine density of visual cortex pyramidal cells in the rat.
• Reproductive and developmental toxicity studies of toluene -- I. teratogenicity study of inhalation exposure in pregnant rats.
• Reproductive and developmental toxicity studies of toluene--II. effects of inhalation exposure on fertility in rats.
• Reproductive and developmental toxicity studies of toluene. III. Prenatal and postnatal study by inhalation exposure in rats.
• Reproductive hazards in the workplace.
• Reproductive health hazards in the workplace: guidelines for policy development and implementation.
• Spontaneous abortions and glycol ethers used in the semiconductor industry: an epidemiologic review.
• The cause and prevention of human birth defects: what have we learned in the past 50 years?
• The developmental consequences of prenatal exposure to abused solvents 1,1,1-trichloroethane and toluene.
• Toluene causes developmental neurotoxicity in rats.
• Toluene effects on Gallus domesticus vestibular sensory epithelia in the embryogenesis.
• Toluene embryopathy syndrome.
• Toluene embryopathy: elucidation of phenotype and mechanism of teratogenesis in 12 patients.
• Toluene embryopathy: elucidation of phenotype and mechanism of teratogenesis in 12 patients.

ECOTOX Documents

• Methylbenzene

ERG2016 Guidebook

• GUIDE 130 (Spanish) - LÍQUIDOS INFLAMABLES (no polar / no mezclables con agua / nocivo)
• GUIDE 130 - FLAMMABLE LIQUIDS (Non-Polar / Water-Immiscible / Noxious)

Fisher MSDS

• (2,4-Dichlorophenyl)-methanesulfonyl chloride
• (4-Methylphenyl)methanesulfonyl chloride (in French)
• (4R)-3-(tert-Butoxycarbonyl)-1,3-thiazolane-4-carboxylic acid

More...

• (5-Phenylisoxazol-3-yl)methylamine
• (R)-(+)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene
• (R)-(+)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene (in French)
• (R)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene
• (R)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene (in French)
• (S)-2-guanidino-3-phenylpropionic acid
• (S)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene
• (S)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene
• (S)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene (in French)
• (S)-2-Methyl-CBS-oxazaborolidine, 1M solution in toluene (in French)
• (Trimethylsilyl)methylmagnesium chloride, 1.1M solution in THF (in French)
• [3-(trifluoromethyl)phenyl]methanesulfonyl chloride (in French)
• [4-(4-Methylpiperazino)phenyl]methanol (in French)
• [Bis(2-methoxyethyl)amino]sulfur trifluoride, 50% solution in toluene (in French)
• 1,2-Phthalic dicarboxaldehyde
• 1,3,5-Trimethyl-1H-pyrazole-4-sulfonyl chloride
• 1,4-Benzodioxan-5-amine
• 1-(2-Hydroxy-1-naphthyl)ethan-1-one (in French)
• 1-(4-Bromo-2-fluorobenzyl)-1,4-diazepane
• 1-(4-Chlorophenoxy)-3-iodopropane 50% solution in toluene
• 1-(4-Chlorophenoxy)-3-iodopropane 50% solution in toluene (in French)
• 1-(4-Chlorophenyl)-5-propyl-1H-pyrazole-4-carboxylic acid
• 1-(4-Cyanophenyl)-4-piperidinecarbohydrazide
• 1-Methyl-1H-pyrazole-4-carbonyl chloride (in French)
• 1-Methylindazole-6-boronic acid
• 1-phenyl-1-pyridin-2-ylmethanamine dihydrochloride (in French)
• 10/PK ANA REDUCIBLE BLOOD AGAR
• 100/CS BHI BROTH 0.5ml
• 100/CS MYCOBIOTIC AG (MYCOCEL)
• 10X OPTIZYME-+ T4 DNA Ligase Buffer
• 10X OPTIZYME-+ T4 PNK Buffer 1
• 1X Tris/EDTA Solution
• 2% OCTPHENOL
• 2,4,6-Tris(tert-butylperoxy)-1,3,5-triazine, 35 wt% sol in toluene and bis(2-ethylhexyl)adipate (in French)
• 2,5-Difluorobenzenesulfonyl chloride
• 2,5-Dimethylphenyl isothiocyanate (in French)
• 2-(1,3-Oxazol-5-yl)aniline
• 2-(2-Chloro-4-fluorophenyl)-N`-hydroxyethanimidamide
• 2-(3-Oxo-1,3-dihydroisobenzofuran-1-yliden)acetic acid (in French)
• 2-(4-Acetylpiperazin-1-yl)pyridine-5-boronic acid, pinacol ester
• 2-(4-Chlorophenyl)-3-oxopropanenitrile (in French)
• 2-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride (in French)
• 2-[(2-Aminoethyl)amino]nicotinic acid (in French)
• 2-Bromo-1-[3,5-di(tert-butyl)-4-hydroxyphenyl]ethan-1-one
• 2-Bromo-3-furoic acid (in French)
• 2-Bromo-4`-methylacetophenone
• 2-Chloro-4-fluorobenzenesulfonyl chloride
• 2-Chloro-5-(trifluoromethyl)pyridine-3-carbonyl chloride
• 2-Chloro-5-isocyanatopyridine (in French)
• 2-Chloro-5-methoxyphenylboronic acid, 97%
• 2-Fluorophenol (in French)
• 2-Methoxypyrimidine-5-boronic acid
• 2-Methyl-2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]propanoic acid (in French)
• 2-Pyrazinecarbonyl chloride
• 2-Pyrazinylmethanol
• 2-Pyrazinylmethanol
• 20/PK BRUCELLA BROTH 5ml
• 20/PK LOEFFLERS MEDIUM SLANT
• 3,3-Dimethylpiperidine hydrochloride
• 3,4-Dihydro-2H-1,4-benzoxazine-2-carboxylic acid (in French)
• 3,5-Dichlorophenylmagnesium bromide, 0.5M solution in tetrahydrofuran
• 3,5-Dimethylisoxazole-4-boronic acid, pinacol ester (in French)
• 3-(2-Oxocyclododecyl)propanoic acid
• 3-(Diphenylphosphino)propylamine
• 3-(Methoxycarbonyl)pyridine-5-boronic acid, pinacol ester
• 3-(N,N-Dimethylmyristylammonio)propanesulfate
• 3-[(2-Furylmethyl)amino]propanenitrile
• 3-[(4-Pyridylmethyl)amino]propanenitrile
• 3-Aminophthalhydrazide (in French)
• 3-Aminopyridine-5-boronic acid, pinacol ester (in French)
• 3-Bromo-2-furoic acid (in French)
• 3-Butoxy-4-methoxybenzoic acid
• 3-Fluoro-4-(trifluoromethoxy)benzaldehyde (in French)
• 3-Methoxyphenylmagnesium bromide, 1M solution in THF/toluene
• 3-Methoxyphenylmagnesium bromide, 1M solution in THF/toluene (in French)
• 4'-methoxy[1,1'-biphenyl]-4-sulfonyl chloride (in French)
• 4-(1,3-Benzothiazol-2-yl)aniline (in French)
• 4-(2-Hydroxyethyl)benzonitrile
• 4-(2-Pyridinyl)benzaldehyde
• 4-(4'-Allyloxycarbonylpiperizino)phenylboronic acid, pinacol ester (in French)
• 4-(Morpholinomethyl)aniline (in French)
• 4-(Piperazine-1-carbonyl)phenylboronic acid, pinacol ester
• 4-Amino-2-(methylthio)pyrimidine-5-carbonitrile
• 4-Chloro-2,6-difluorobenzaldehyde
• 4-Chloro-5-fluoro-o-phenylenediamine
• 4-Chlorophenylmagnesium bromide, 0.9M solution in THF/toluene (in French)
• 4-Fluoroaniline
• 4-Fluorophenol (in French)
• 4-Methylmorpholine N-oxide, 50% wt.% solution in water
• 4-Nitro-5-piperazinothiophene-2-sulfonamide (in French)
• 4-Tetrahydro-1H-pyrrol-1-ylpent-3-en-2-one (in French)
• 5-(3-Bromophenyl)-1-methyl-1H-pyrazole (in French)
• 5-Amino-2-methylindole (in French)
• 5-Amino-3-methylisoxazole (in French)
• 5-Bromo-1-(phenylsulfonyl)-1H-indole
• 5-Fluoro-2-(trifluoromethyl)pyridine
• 5-Iodo-1-methyl-1H-pyrazole (in French)
• 5-methyl-3-isoxazolecarbaldehyde
• 5-Phenyl-1,3,4-oxadiazole-2-carbonyl chloride
• 6-Bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene (in French)
• 6/PK 10B BROTH (LYOPH) 1.8 ml
• 6/PK A3B BROTH (LIQUID) 1.8 ml
• 6/PK ARGININE BR (LYOPH) 1.8ml
• 7-Hydroxy-4-oxo-8-propyl-4H-chromene-2-carboxylic acid
• 8-Amino-6-chloro-4H-benzo[1,4]oxazin-3-one (in French)
• 95% Ethanol
• Acetonitrile
• Adenosine 5'-monophosphate sodium salt
• Amberlyst A26 hydroxide form
• Bacillus cereus Selective Supplement
• BactiCard Mugal Reagent
• Bactidrop Ninhydrin reagent (in French)
• Bactidrop TM Nitrate A
• BactidropTM Desoxycholate (10%)
• Benzine (Petroleum Naphtha)
• Benzine (Petroleum Naphtha) (in French)
• Benzyl 4-oxo-1-piperidinecarboxylate
• Benzyl chloroformate, 50 wt% solution in toluene
• Benzyl chloroformate, 50 wt% solution in toluene (in French)
• Bis(cyclopentadienyl)dimethyltitanium, 5 wt% solution in toluene (in French)
• Cary-Blair
• CBZ-L-Serine methyl ester
• Chromone-3-carboxaldehyde (in French)
• Clear Vue Mount
• Clear Vue Mount (in French)
• ClearVue Mount
• ClearVue Mount (in French)
• COAGULASE PLASMA 15ml
• COAGULASE PLASMA 5ml
• COLUMBIA BLOOD AGAR
• Congo Red Solution (in French)
• Cyclohexylmagnesium chloride, 1.3M solution in THF/toluene (in French)
• Cytoseal-+ 280
• Cytoseal-+ 280
• Cytoseal-+ 280 (in French)
• Cytoseal-+ 280 (in French)
• Cytoseal-+ 60
• Cytoseal-+ 60
• Cytoseal-+ 60 (in French)
• Cytoseal-+ 60 (in French)
• Deblock, 3% DCA-IVT
• Deblock, 3% DCA-IVT (in French)
• Dehydrant 70% (in French)
• Dewax HIER Buffer H (in French)
• Dewax HIER Buffer L (in French)
• Dichloroacetic acid, 1-5% in toluene
• Dichloroacetic acid, 1-5% in toluene (in French)
• Diethylaluminium chloride, 0.9M solution in toluene (in French)
• Diethylaluminium chloride, 1.1M solution in toluene (in French)
• Diethylaluminium ethoxide, 25 wt% solution in toluene
• Diethylaluminium ethoxide, 25 wt% solution in toluene
• Diethylaluminium ethoxide, 25 wt% solution in toluene (in French)
• Diethylaluminium ethoxide, 25 wt% solution in toluene (in French)
• Diethylaluminium iodide, 0.9M solution in toluene (in French)
• Diethylaluminium iodide, 1.1M solution intoluene
• Diethylaluminium iodide, 1.1M solution intoluene (in French)
• Diethylzinc, solution in toluene (in French)
• Diisobutylaluminium hydride, 20 wt% solution in toluene
• Diisobutylaluminium hydride, 20 wt% solution in toluene (in French)
• Dimethylglyoxime
• Dimethylzinc, 1.2M solution in toluene (in French)
• EA-50 (in French)
• Eosin-Y Alcoholic (in French)
• Ethanol SDA1, Anhydrous
• Ethanol SDA1, Anhydrous (in French)
• Ethanol, CDA 19
• Ethanol, CDA 19 (in French)
• Ethoxymethylenemalononitrile (in French)
• Ethyl 2-amino-4-thiazoleacetate
• Ethyl Alcohol Denatured
• Ethyl Alcohol Denatured (in French)
• Ethylaluminium dichloride, 1.8M solution in toluene
• Ethylaluminium dichloride, 1.8M solution in toluene (in French)
• Ethynylcyclopropane, 70 wt% solution in toluene
• Ethynylcyclopropane, 70 wt% solution in toluene (in French)
• Ethynylmagnesium chloride, 0.6M solution in THF/toluene
• Ethynylmagnesium chloride, 0.6M solution in THF/toluene (in French)
• Ethynylmagnesium chloride, 1.1M solution in THF/toluene (in French)
• EZ Slip Activator
• Fast Flex Paraffin (in French)
• FLAGELLA STAIN RYU
• Formaldehyde 37% Solution
• General Conjugate Diluent (w/o dye) (in French)
• Gold chloride solution (in French)
• Gram Iodine (concentrate)
• Gram Iodine (GALLON)
• Gram Iodine (Pk/5)
• Hema Quik II
• Histoprep Acetone (in French)
• Histoprep Xylene
• Histoprep Xylene (in French)
• KIT/24 PROSPECT CRYPTO MP
• KIT/50 STREPTEX KIT
• Lactophenol
• Lerner D-Calcifier (in French)
• Lerner EA-65 Counterstain (in French)
• Lithium aluminium hydride, 15% solution in toluene/THF
• Lithium aluminium hydride, 15% solution in toluene/THF (in French)
• LYSINE IRON AGAR MODIFIED 500G
• MACCONKEY AGAR 100GM
• Methyl 2-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoate
• Methyl 4-bromo-3-hydroxythiophene-2-carboxylate
• Methylaluminoxane, 10 wt.% (1.5M) solution in toluene
• Methylaluminoxane, 10 wt.% (1.5M) solution in toluene (in French)
• Methylaluminum sesquichloride, 1M solution in toluene
• Methylaluminum sesquichloride, 1M solution in toluene (in French)
• Methylene Blue hydrate
• Methylmagnesium bromide, 1.4M solution in toluene/THF (in French)
• MICHEL`S MEDIUM
• MICROLOOPS
• Mounting Medium
• Mounting Medium
• Mounting Medium
• Mounting Medium (in French)
• Mounting Medium Quanto
• Mounting Medium Quanto (in French)
• Mounting Medium T
• Mounting Medium T (in French)
• Mounting Medium T (in French)
• Mounting Medium T (in French)
• Mucolytic Agent (in French)
• N,N'-Di-BOC-1H-pyrazole-1-carboxamidine
• N,N-Dimethyl-L-valine
• N-alpha-Carbobenzyloxy-L-asparagine (in French)
• n-Butyllithium, 2.6M solution in toluene (in French)
• n-Butylmagnesium chloride, 20 wt% solution in THF/Toluene
• n-Butylmagnesium chloride, 20 wt% solution in THF/Toluene (in French)
• NITRATE A REAGENT 15ml
• o-Tolylmagnesium chloride, 1.4M (22 wt.%) solution in THF/touene
• o-Tolylmagnesium chloride, 1.4M (22 wt.%) solution in THF/touene (in French)
• OPTIZYME-+ AVA I
• OPTIZYME-+ DPN I
• OPTIZYME-+ NDE I
• OPTIZYME-+ SPE I
• Orange G
• p-Naphtholbenzein indicator solution
• p-Naphtholbenzein indicator solution (in French)
• para-Naphtholbenzein indicator solution
• para-Naphtholbenzein indicator solution (in French)
• PEN-FIX (in French)
• Pentyl isothiocyanate
• Permount Mounting Media
• Permount Mounting Media
• Permount Mounting Media
• Permount Mounting Media (in French)
• PERMOUNT MOUNTING MEDIA (in French)
• PERMOUNT MOUNTING MEDIA (in French)
• PHADEBACT POSITIVE CONTROLS
• PHOS BUFFER w/MgCl
• PK/6 COAGULASE PLASMA 5ml
• Poly(2-ethylhexyl acrylate), 32% solids solution in toluene, average M.W. 92.000
• Poly(2-ethylhexyl acrylate), 32% solids solution in toluene, average M.W. 92.000 (in French)
• Poly(hexadecyl methacrylate), 28% solution in toluene, average M.W. 190.000
• Poly(hexadecyl methacrylate), 28% solution in toluene, average M.W. 190.000 (in French)
• Poly(methyl acrylate), solution in toluene, average M.W. ca. 40000 (GPC)
• Poly(methyl acrylate), solution in toluene, average M.W. ca. 40000 (GPC) (in French)
• Potassium bis(trimethylsilyl)amide, 0.5M solution in toluene
• Potassium bis(trimethylsilyl)amide, 0.5M solution in toluene (in French)
• Potassium methoxide
• Potassium methoxide (in French)
• Potassium nitrate
• Potassium tetrachloroplatinate(II)
• Propargyl bromide, 80 wt% solution in toluene, stabilized
• Propargyl bromide, 80 wt% solution in toluene, stabilized
• Propargyl bromide, 80 wt% solution in toluene, stabilized (in French)
• Propargyl bromide, 80 wt% solution in toluene, stabilized (in French)
• PROSPECT CAMPY MP
• Protocol Lugol's Iodine (in French)
• PSEUDOMONAS P AGAR 100GM
• PVA - FORM 10
• PVA Fixative
• PVA Low Viscosity Fixative
• REMEL BACTISWAB BACTERIOLOGY CULTURE COLLECTION AND TRANSPORT SYSTEM WITH MODIFIED AMIES CLEAR
• Remel Prepared Culture Media Containing Kanamycin, and Nalidixic acid
• RPR CARD 500 TEST
• S/P Toluene
• S/P Xylenes
• Schaudinn`s Fixative
• Securemount, High Viscosity
• SECUREMOUNT, HIGH VISCOSITY
• Securemount, High Viscosity
• Securemount, High Viscosity (in French)
• Shandon Consul Mount Histology (in French)
• Shandon Flo-Texx
• Shandon Flo-Texx (in French)
• Shandon Histomount Xylene Substitute Mountant
• Shandon Histomount Xylene Substitute Mountant (in French)
• Shandon Mount
• Shandon Mount (in French)
• Shandon Synthetic Mount
• Shandon Synthetic Mount (in French)
• Shandon Xylene
• Shandon Xylene (in French)
• Silver nitrate, 0.1N standard solution
• SIMMONS CITRATE AGAR 500GM
• Sodium bis(2-methoxyethoxy)aluminiumhydride, 70 wt% sol. in toluene (ca. 3.5M)
• Sodium bis(2-methoxyethoxy)aluminiumhydride, 70 wt% sol. in toluene (ca. 3.5M)
• Sodium bis(2-methoxyethoxy)aluminiumhydride, 70 wt% sol. in toluene (ca. 3.5M) (in French)
• Sodium bis(2-methoxyethoxy)aluminiumhydride, 70 wt% sol. in toluene (ca. 3.5M) (in French)
• Sodium, 30 wt% dispersion in toluene, <0.1 mm particle size (in French)
• SurePrep-+ RNA/DNA/Protein Purification Kit, RNA Wash Solution
• TAT BROTH BASE 500GM
• TB Malachite Green
• TB Potassium Permanganate
• Tebbe reagent, 0.5M solution in toluene
• Tebbe reagent, 0.5M solution in toluene
• Tebbe reagent, 0.5M solution in toluene (in French)
• Tebbe reagent, 0.5M solution in toluene (in French)
• tert-Butyl (S)-4-(dimethylamino)-1-(piperazine-1-carbonyl)butylcarbamate (in French)
• tert-Butyl 4-[(trifluoromethyl)sulfonyloxy]-5,6-dihydropyridine-1(2H)-carboxylate (in French)
• tert-Butyl 4-[4-(aminomethyl)benzyloxy]piperidine-1-carboxylate (in French)
• tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate (in French)
• tert-Butyldimethylsilyl chloride, 50 wt.% solution in toluene
• tert-Butyldimethylsilyl chloride, 50 wt.% solution in toluene (in French)
• Tetrabutylammonium hydroxide, 0.1N sol. in toluene/methanol
• Tetrabutylammonium hydroxide, 0.1N sol. in toluene/methanol (in French)
• Tetrabutylammonium Hydroxide, 0.1N Solution in Toluene/Methanol for non-aq. titr.
• Tetrabutylammonium Hydroxide, 0.1N Solution in Toluene/Methanol for non-aq. titr.
• Tetrabutylammonium Hydroxide, 0.1N Solution in Toluene/Methanol for non-aq. titr. (in French)
• Tetrabutylammonium Hydroxide, 0.1N Solution in Toluene/Methanol for non-aq. titr. (in French)
• THIO MED w/DEX, HEM, VIT K
• Titanium(IV) chloride, 1M solution in toluene
• Titanium(IV) chloride, 1M solution in toluene (in French)
• Titration solvent
• Titration solvent (in French)
• Toluene
• TOLUENE
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene
• Toluene (in French)
• TOLUENE (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene (in French)
• Toluene-d8
• Toluene-d8
• Toluene-d8
• Toluene-d8
• Toluene-d8
• Toluene-d8
• Toluene-d8 (in French)
• Toluene-d8 (in French)
• Toluene-d8 (in French)
• Toluene-d8 (in French)
• Toluene-d8 (in French)
• Toluene-d8 (in French)
• Toluene/Acetone V/V 50/50
• Toluene/Acetone V/V 50/50 (in French)
• Tricyclohexylphosphine, 1M solution in toluene
• Tricyclohexylphosphine, 1M solution in toluene (in French)
• Triisobutylaluminium, solution in toluene (in French)
• Tris(2-thienyl)phosphine
• Tris(hydroxymethyl)aminomethane hydrochloride
• Type L Paraffin (in French)
• XPECT CRYPTOSPORIDIUM KIT
• Xylene
• Xylene (in French)

GENE-TOX Documents

• TOLUENE

HSDB® Data Bank

• TOLUENE

IRIS Documents

• Toluene

LOLI® Listings

• Toluene ( 108-88-3)

NIOSH Documents

• Toluene

New Jersey Fact Sheets

• TOLUENE
• TOLUENE (in Spanish)

NTP - Long-Term Studies

• Toxicology and Carcinogenesis Studies of Toluene (CAS No.108-88-3) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) (Report Date: 1990)

OHM/TADS Documents

• TOLUENE

REPROTOX® Documents

• TOLUENE

RTECS® Registry

• Toluene

Shepard's Catalog

• Toluene

TERIS Documents

• TOLUENE

ToxRes Database

• Toluene
• Toluene
• Toluene

More...

• Toluene

MSDSonline®

(3198) English MSDSs - (click to search other languages)

ChemID External Links:

ATSDR Tox Portal

Toluene

CAMEO

Toluene

ChEBI

Toluene

ClinicalTrials.gov

Toluene

CPDB

Toluene

CTD

Toluene

DailyMed

Toluene

DART

Toluene

DrugPortal

Toluene

ECHA

Toluene

eChemPortal

Toluene

EMIC

Toluene

EPA ACToR

Toluene

EPA Envirofacts

Toluene

EPA SRS

Toluene

Household Products

Toluene

ITER

Toluene

MedlinePlusAll

Toluene

MeSH

Toluene

MeSH Heading

Toluene

NIOSH ICSC

Toluene

NIST WebBook

Toluene

OSHA Chem

Toluene

OSHA ChemDB

Toluene

PubChem

Toluene

PubMed

Toluene

PubMed AIDS

Toluene

PubMed Cancer

Toluene

PubMed Toxicology

Toluene

SRC CHEMFATE

Toluene

SRC DATALOG

Toluene

Tox Town

Toluene

TOXLINE

Toluene

TOXMAP

Toluene

TRI2000

Toluene

TRI2001

Toluene

TRI2002

Toluene

TRI2003

Toluene

TRI2004

Toluene

TRI2005

Toluene

TRI2006

Toluene

TRI2007

Toluene

TRI2008

Toluene

TRI2009

Toluene

TRI2010

Toluene

TRI2011

Toluene

TRI2012

Toluene

TRI2013

Toluene

TRI95

Toluene

TRI96

Toluene

TRI97

Toluene

TRI98

Toluene

TRI99

Toluene

USA.gov

Toluene

WebWISER

Toluene

Other Government Links Searched via RegsKnowledge:

State Environmental Regulations

• Show Matching State Regulations

CFR Regulations

• Show Matching CFR Regulations

Example Content from MEDITEXT for 108-88-3:

ACUTE EXPOSURE INFORMATION

1. USES: Toluene (toluol, methyl benzene) is an aromatic petroleum hydrocarbon that has many commercial and industrial applications. It is used as a solvent and starting material for organic synthesis and is found in paints, paint thinners, glues, and other products. Toluene products are abused via inhalation for their intoxicating effects.

2. TOXICOLOGY: It has long been held that toluene's effect on the central nervous system are via nonspecific lipophilic membrane interactions, which in turn modulates several neurotransmitter systems (ie, dopamine, acetylcholine, GABA, glycine, and serotonin).

3. EPIDEMIOLOGY: Exposures are common, but significant toxicity is generally only seen in the setting of deliberate inhalation abuse and deaths are rare.

4. WITH POISONING/EXPOSURE
   1. MILD TO MODERATE TOXICITY: Acute ingestion causes CNS depression, oropharyngeal and gastric pain and vomiting. Splash exposure to eyes may cause irritation, burning, blepharospasm, conjunctivitis, corneal edema, and corneal abrasions. Symptoms usually resolve within 48 hours. Prolonged or repeated dermal exposures may result in a defatting dermatitis. Occupational exposure has been linked to an increased risk of esophageal and rectal cancers as well as increased mortality from bone and connective tissue cancers.
   2. SEVERE TOXICITY: Acute inhalation produces a biphasic response with an initial CNS excitation followed by CNS depression, which is characterized by ataxia, fatigue, sedation, occasionally seizures, and at very high concentrations general anesthesia. Sudden death may occur from hypoxia or cardiac dysrhythmias. Chronic inhalational abuse is associated with muscular weakness, gastrointestinal symptoms (pain, nausea, vomiting), renal tubular acidosis (hypokalemia and metabolic acidosis), hepatic injury, and neuropsychiatric symptoms. Patients who chronically abuse toluene may exhibit hypokalemia, hematuria, proteinuria, oliguria, paresis, rhabdomyolysis, hallucinations, hyperactive reflexes, peripheral neuropathy, personality changes, tremors, headaches, emotional lability, and memory loss. Patients with long-term inhalational abuse may develop progressive irreversible encephalopathy with cognitive difficulty and cerebellar ataxia. Significant inhalational exposure causes an easily recognized odor to the breath that may persist for several days after exposure ceases. There are a small number of case reports of mothers who regularly abused toluene recreationally during pregnancy giving birth to children with microcephaly, CNS dysfunction, and minor head, face and limb anomalies. However, some of these mothers also abused ethanol as well.